Anti‐CD3‐based bispecific antibody designed for therapy of human B‐cell malignancy can induce T‐cell activation by antigen‐dependent and antigen‐independent mechanisms

Overview of attention for article published in International Journal of Cancer, December 1998

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

patent: 47 patents

wikipedia: 3 Wikipedia pages

Readers on

mendeley: 19 Mendeley

So far, Altmetric has seen 47 patents that reference this research output.

Multi-specific antibodies binding to BCMA

Grant US-12747298-B2

United States of America

29 Sep 2026

Anti-MUC1-C antibodies and CAR-T structures

Grant US-12735503-B2

United States of America

15 Sep 2026

Anti-CD20 antibodies and CAR-T structures

Grant US-12709644-B2

United States of America

18 Aug 2026

Methods of modifying antibodies for purification of bispecific antibodies

Grant US-RE50968-E1

United States of America

28 Jul 2026

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 43 additional patents.